Products & Services · Percent Change (as a percent)
OPSUMIT/OPSYNVI — Percent Change (as a percent)
Johnson & Johnson OPSUMIT/OPSYNVI — Percent Change (as a percent) increased by 2112.5% to 16.1% in Q1 2026 compared to the prior quarter. This is a positive signal — higher values indicate stronger performance for this metric.
Analysis
StatementSegment
CategoryGrowth
SignalHigher is better
VolatilityModerate
First reportedQ1 2025
Last reportedQ1 2026Apr 22, 2026
How to read this metric
A positive percentage indicates accelerating market penetration or pricing power, whereas a negative percentage suggests market saturation or loss of exclusivity.
Detailed definition
This metric measures the period-over-period growth rate of revenue for a specific pharmaceutical product line. It isolat...
Peer comparison
Comparable to organic segment growth rates or product-specific revenue growth metrics provided by peer pharmaceutical firms.
Metric ID:
jnj_segment_opsumit_opsynvi_percent_change_as_a_percentHistorical Data
4 periods
| Q1 '25 | Q2 '25 | Q3 '25 | Q1 '26 | |
|---|---|---|---|---|
| Value | -0.5% | 6.4% | -0.8% | 16.1% |
| QoQ Change | — | >999% | -112.5% | >999% |
| YoY Change | — | — | — | >999% |
Range-0.8% – 16.1%
Avg YoY Growth>999%
Median YoY Growth>999%
Similar Metrics at Other Companies
Frequently Asked Questions
- What is Johnson & Johnson's opsumit/opsynvi — percent change (as a percent)?
- Johnson & Johnson (JNJ) reported opsumit/opsynvi — percent change (as a percent) of 16.1% in Q1 2026.
- What does opsumit/opsynvi — percent change (as a percent) mean?
- The percentage growth or decline in revenue for a specific product line compared to the previous period.